Altitude sickness epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(15 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Altitude sickness}}
{{Altitude sickness}}
{{CMG}}
{{CMG}} {{AE}} {{F.K}}
 
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.


==Overview==
==Overview==
With a rapid ascension to high altitudes in 1 to 3 days, more than 50% of people develop altitude sickness. The incidence of clinical HAPE in unacclimatized travelers exposed to high altitude (~ 4,000 m) appears to be less than 1%. In over 30 years of research experience, the [[United States Army Pike’s Peak Research Laboratory|U.S. Army Pike's Peak Research Laboratory]], utilizing about 300 sea-level resident volunteers (and more than 100 staff members) rapidly and directly exposed to high altitude, only 3 were evacuated with suspected HAPE.
The [[incidence]] of altitude sickness is approximately 53,000 per 100,000 individuals worldwide. The [[prevalence]] and [[mortality rate]] of altitude sickness depends on altitude. Patients of all age groups may develop altitude sickness. The [[incidence]] of altitude sickness increases with age; the [[median]] age at [[diagnosis]] is 26-45 years. There is no racial predilection to altitude sickness. The majority of altitude sickness cases are reported in Kilimanjaro, Everest region of Nepal.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence of altitude sickness is approximately 53,000 per 100,000 individuals worldwide.<ref name="pmid62991">{{cite journal |vauthors=Hackett PH, Rennie D, Levine HD |title=The incidence, importance, and prophylaxis of acute mountain sickness |journal=Lancet |volume=2 |issue=7996 |pages=1149–55 |date=November 1976 |pmid=62991 |doi= |url=}}</ref><ref name="pmid21718562">{{cite journal |vauthors=Murdoch D |title=Altitude sickness |journal=BMJ Clin Evid |volume=2010 |issue= |pages= |date=March 2010 |pmid=21718562 |pmc=2907615 |doi= |url=}}</ref>
*The [[incidence]] of altitude sickness is approximately 53,000 per 100,000 individuals worldwide.<ref name="pmid62991">{{cite journal |vauthors=Hackett PH, Rennie D, Levine HD |title=The incidence, importance, and prophylaxis of acute mountain sickness |journal=Lancet |volume=2 |issue=7996 |pages=1149–55 |date=November 1976 |pmid=62991 |doi= |url=}}</ref><ref name="pmid21718562">{{cite journal |vauthors=Murdoch D |title=Altitude sickness |journal=BMJ Clin Evid |volume=2010 |issue= |pages= |date=March 2010 |pmid=21718562 |pmc=2907615 |doi= |url=}}</ref>


===Prevalence===
===Prevalence===
*The prevalence of altitude sickness is approximately as following:<ref name="pmid21718562">{{cite journal |vauthors=Murdoch D |title=Altitude sickness |journal=BMJ Clin Evid |volume=2010 |issue= |pages= |date=March 2010 |pmid=21718562 |pmc=2907615 |doi= |url=}}</ref><ref name="pmid21190503">{{cite journal |vauthors=Mairer K, Wille M, Burtscher M |title=The prevalence of and risk factors for acute mountain sickness in the Eastern and Western Alps |journal=High Alt. Med. Biol. |volume=11 |issue=4 |pages=343–8 |date=2010 |pmid=21190503 |doi=10.1089/ham.2010.1039 |url=}}</ref>
*The [[prevalence]] of altitude sickness is approximately as following:<ref name="pmid21718562">{{cite journal |vauthors=Murdoch D |title=Altitude sickness |journal=BMJ Clin Evid |volume=2010 |issue= |pages= |date=March 2010 |pmid=21718562 |pmc=2907615 |doi= |url=}}</ref><ref name="pmid21190503">{{cite journal |vauthors=Mairer K, Wille M, Burtscher M |title=The prevalence of and risk factors for acute mountain sickness in the Eastern and Western Alps |journal=High Alt. Med. Biol. |volume=11 |issue=4 |pages=343–8 |date=2010 |pmid=21190503 |doi=10.1089/ham.2010.1039 |url=}}</ref>
**9000 per 100,000 individuals of people at 2850 m  
**9000 per 100,000 individuals of people at 2850 m  
**13000 per 100,000 individuals of people at 3050 m  
**13000 per 100,000 individuals of people at 3050 m  
Line 20: Line 18:


===Case-fatality rate/Mortality rate===
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The [[mortality rate]] of altitude sickness is approximately as following:<ref name="pmid25110611">{{cite journal |vauthors=Burtscher M |title=Effects of living at higher altitudes on mortality: a narrative review |journal=Aging Dis |volume=5 |issue=4 |pages=274–80 |date=August 2014 |pmid=25110611 |doi=10.14336/AD.2014.0500274 |url=}}</ref><ref name="pmid23908794">{{cite journal |vauthors=Taylor AT |title=High-altitude illnesses: physiology, risk factors, prevention, and treatment |journal=Rambam Maimonides Med J |volume=2 |issue=1 |pages=e0022 |date=January 2011 |pmid=23908794 |pmc=3678789 |doi=10.5041/RMMJ.10022 |url=}}</ref>
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
**289 per 100,000 individuals in men below 300 m of altitude
**242 per 100,000 individuals in men at altitudes above 1500 m
**104 per 100,000 individuals in women at below 300 m of altitude
**74 per 100,000 individuals in women at altitude 1500 to 1960 m


===Age===
===Age===
*Patients of all age groups may develop [disease name].
*Patients of all age groups may develop altitude sickness.<ref name="pmid24130729">{{cite journal |vauthors=MacInnis MJ, Carter EA, Freeman MG, Pandit BP, Siwakoti A, Subedi A, Timalsina U, Widmer N, Thapa GB, Koehle MS, Rupert JL |title=A prospective epidemiological study of acute mountain sickness in Nepalese pilgrims ascending to high altitude (4380 m) |journal=PLoS ONE |volume=8 |issue=10 |pages=e75644 |date=2013 |pmid=24130729 |pmc=3794000 |doi=10.1371/journal.pone.0075644 |url=}}</ref>
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*The [[incidence]] of altitude sickness increases with age; the median age at diagnosis is 26-45 years.<ref name="pmid25120358">{{cite journal |vauthors=Tang XG, Zhang JH, Qin J, Gao XB, Li QN, Yu J, Ding XH, Huang L |title=Age as a risk factor for acute mountain sickness upon rapid ascent to 3,700 m among young adult Chinese men |journal=Clin Interv Aging |volume=9 |issue= |pages=1287–94 |date=2014 |pmid=25120358 |pmc=4128797 |doi=10.2147/CIA.S67052 |url=}}</ref>
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===
*There is no racial predilection to [disease name].
*There is no racial predilection to altitude sickness.
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 
===Gender===
===Gender===
*[Disease name] affects men and women equally.
*Female are more commonly affected by altitude sickness than male.<ref name="pmid23908794">{{cite journal |vauthors=Taylor AT |title=High-altitude illnesses: physiology, risk factors, prevention, and treatment |journal=Rambam Maimonides Med J |volume=2 |issue=1 |pages=e0022 |date=January 2011 |pmid=23908794 |pmc=3678789 |doi=10.5041/RMMJ.10022 |url=}}</ref>
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
 
===Region===
===Region===
*The majority of [disease name] cases are reported in [geographical region].
*The majority of altitude sickness cases are reported in Kilimanjaro, Everest region of Nepal.<ref name="pmid23908794">{{cite journal |vauthors=Taylor AT |title=High-altitude illnesses: physiology, risk factors, prevention, and treatment |journal=Rambam Maimonides Med J |volume=2 |issue=1 |pages=e0022 |date=January 2011 |pmid=23908794 |pmc=3678789 |doi=10.5041/RMMJ.10022 |url=}}</ref><ref name="pmid9774298">{{cite journal |vauthors=Peacock AJ |title=ABC of oxygen: oxygen at high altitude |journal=BMJ |volume=317 |issue=7165 |pages=1063–6 |date=October 1998 |pmid=9774298 |pmc=1114067 |doi= |url=}}</ref>
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
===Developed Countries===
 
===Developing Countries===


==References==
==References==

Latest revision as of 19:49, 15 March 2018

Altitude sickness Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Altitude Sickness from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Altitude sickness epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Altitude sickness epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Altitude sickness epidemiology and demographics

CDC on Altitude sickness epidemiology and demographics

Altitude sickness epidemiology and demographics in the news

Blogs on Altitude sickness epidemiology and demographics

Directions to Hospitals Treating Altitude sickness

Risk calculators and risk factors for Altitude sickness epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

The incidence of altitude sickness is approximately 53,000 per 100,000 individuals worldwide. The prevalence and mortality rate of altitude sickness depends on altitude. Patients of all age groups may develop altitude sickness. The incidence of altitude sickness increases with age; the median age at diagnosis is 26-45 years. There is no racial predilection to altitude sickness. The majority of altitude sickness cases are reported in Kilimanjaro, Everest region of Nepal.

Epidemiology and Demographics

Incidence

  • The incidence of altitude sickness is approximately 53,000 per 100,000 individuals worldwide.[1][2]

Prevalence

  • The prevalence of altitude sickness is approximately as following:[2][3]
    • 9000 per 100,000 individuals of people at 2850 m
    • 13000 per 100,000 individuals of people at 3050 m
    • 34000 per individuals of people at 3650 m
    • 53,000 per 100,000 individuals of people at 4559 m

Case-fatality rate/Mortality rate

  • The mortality rate of altitude sickness is approximately as following:[4][5]
    • 289 per 100,000 individuals in men below 300 m of altitude
    • 242 per 100,000 individuals in men at altitudes above 1500 m
    • 104 per 100,000 individuals in women at below 300 m of altitude
    • 74 per 100,000 individuals in women at altitude 1500 to 1960 m

Age

  • Patients of all age groups may develop altitude sickness.[6]
  • The incidence of altitude sickness increases with age; the median age at diagnosis is 26-45 years.[7]

Race

  • There is no racial predilection to altitude sickness.

Gender

  • Female are more commonly affected by altitude sickness than male.[5]

Region

  • The majority of altitude sickness cases are reported in Kilimanjaro, Everest region of Nepal.[5][8]

References

  1. ↑ Hackett PH, Rennie D, Levine HD (November 1976). "The incidence, importance, and prophylaxis of acute mountain sickness". Lancet. 2 (7996): 1149–55. PMID 62991.
  2. ↑ 2.0 2.1 Murdoch D (March 2010). "Altitude sickness". BMJ Clin Evid. 2010. PMC 2907615. PMID 21718562.
  3. ↑ Mairer K, Wille M, Burtscher M (2010). "The prevalence of and risk factors for acute mountain sickness in the Eastern and Western Alps". High Alt. Med. Biol. 11 (4): 343–8. doi:10.1089/ham.2010.1039. PMID 21190503.
  4. ↑ Burtscher M (August 2014). "Effects of living at higher altitudes on mortality: a narrative review". Aging Dis. 5 (4): 274–80. doi:10.14336/AD.2014.0500274. PMID 25110611.
  5. ↑ 5.0 5.1 5.2 Taylor AT (January 2011). "High-altitude illnesses: physiology, risk factors, prevention, and treatment". Rambam Maimonides Med J. 2 (1): e0022. doi:10.5041/RMMJ.10022. PMC 3678789. PMID 23908794.
  6. ↑ MacInnis MJ, Carter EA, Freeman MG, Pandit BP, Siwakoti A, Subedi A, Timalsina U, Widmer N, Thapa GB, Koehle MS, Rupert JL (2013). "A prospective epidemiological study of acute mountain sickness in Nepalese pilgrims ascending to high altitude (4380 m)". PLoS ONE. 8 (10): e75644. doi:10.1371/journal.pone.0075644. PMC 3794000. PMID 24130729.
  7. ↑ Tang XG, Zhang JH, Qin J, Gao XB, Li QN, Yu J, Ding XH, Huang L (2014). "Age as a risk factor for acute mountain sickness upon rapid ascent to 3,700 m among young adult Chinese men". Clin Interv Aging. 9: 1287–94. doi:10.2147/CIA.S67052. PMC 4128797. PMID 25120358.
  8. ↑ Peacock AJ (October 1998). "ABC of oxygen: oxygen at high altitude". BMJ. 317 (7165): 1063–6. PMC 1114067. PMID 9774298.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Altitude_sickness_epidemiology_and_demographics&oldid=1454476"